Logo for Accelerate Diagnostics Inc

Accelerate Diagnostics Investor Relations Material

Latest events

Logo for Accelerate Diagnostics Inc

Q1 2024

Accelerate Diagnostics
Logo for Accelerate Diagnostics

Q1 2024

8 May, 2024
Logo for Accelerate Diagnostics

Q4 2023

28 Mar, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Accelerate Diagnostics Inc

Access all reports
Accelerate Diagnostics, Inc. (Accelerate), an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company's diagnostic platform utilizes its proprietary sandwich immunoassay technology to develop and commercialize assays that support the detection of clinically important viruses and bacteria associated with serious human diseases. Accelerate has developed a pipeline of diagnostic tests, including Carbapenemase (KPC) Nares Panel Kit; Meningitis Panel Kit; and Ebola Quick Test.